Differences between graft-versus-leukemia and graft-versus-host reactivity .1. Interaction of donor immune T cells with tumor and/or host cells

被引:26
作者
Rocha, M
Umansky, V
Lee, KH
Hacker, HJ
Benner, A
Schirrmacher, V
机构
[1] DEUTSCH KREBSFORSCHUNGSZENTRUM, ABT ZELLULARE IMMUNOL, FSP TUMORIMMUNOL, D-69120 HEIDELBERG, GERMANY
[2] DEUTSCH KREBSFORSCHUNGSZENTRUM, ABT EXPT PATHOL, FSP KREBSRISIKOFAKTOREN & KREBSPRAVENT, HEIDELBERG, GERMANY
[3] DEUTSCH KREBSFORSCHUNGSZENTRUM, BIOSTAT ABT, FSP BIOINFORMAT, HEIDELBERG, GERMANY
关键词
D O I
10.1182/blood.V89.6.2189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-leukemia (GVL) and Graft-versus-host (GVH) reactions were compared after systemic transfer of allogeneic antitumor immune T lymphocytes from B10.D2 (H-2(d); Mls(b)) into DBA/2 (H-2(d); Mls(8)) mice. Before immune cell transfer, recipient DBA/2 mice were sublethally irradiated with 5 G gamma to prevent host-versus-graft reactivity. Recipients were either bearing syngeneic metastatic ESb lymphomas (GVL system) or were normal, non-tumor-bearing mice (GVH system). We previously reported that this adoptive immunotherapy protocol (ADI) had pronounced GVL activity and led to immune rejection of even advanced metastasized cancer. In this study, monoclonal antibodies were used for immunohistochemical analysis of native frozen tissue sections from either spleen or liver to distinguish donor from host cells, to differentiate between CD4 and CD8 T lymphocytes, and to stain sialoadhesin-positive macrophages at different time points after cell transfer, The kinetics of donor cell infiltration in spleen and liver differed in that the lymphoid organ was infiltrated earlier (days 1 to 5 after transfer) than the nonlymphoid organ (days 5 to 20), After reaching a peak, donor cell infiltration decreased gradually and was not detectable in the spleen after day 20 and in the liver after day 30. The organ-infiltrating donor immune cells were mostly T lymphocytes and stained positive for CD4 or CD8 T-cell markers. A remarkable GVL-associated observation was made with regard to a subset of macrophages bearing the adhesion molecule sialoadhesin (SER(+) macrophages), In the livers of tumor-bearing mice, their numbers increased between days 1 and 12 after ADI by a factor greater than 30. Double-staining for donor cell marker and SER showed that the sialoadhesin-expressing macrophages were of host origin. The SER(+) host macrophages from GVL livers were isolated by enzyme perfusion and resetting 12 days after ADI, when they reached peak values of about 60 cells per liver lobule, and were tested, without further antigen addition, for their capacity to stimulate an antitumor CD8 T-cell response. The results of this immunologic analysis suggest that these cells in the liver function as scavengers of the destroyed metastases and as antigen-processing and -presenting cells for antitumor immune T cells. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2189 / 2202
页数:14
相关论文
共 49 条
[11]  
FESTENSTEIN H, 1973, TRANSPLANT REV-DENMA, V15, P62
[12]  
FICHTNER KP, IN PRESS MAGNET RESO
[13]   GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER BONE-MARROW TRANSPLANTATION DOES NOT REQUIRE GRAFT-VERSUS-HOST DISEASE [J].
GLASS, B ;
UHAREK, L ;
GASSMANN, W ;
FOCKS, B ;
BOLOURI, H ;
LOEFFLER, H ;
MUELLERRUCHHOLTZ, W .
ANNALS OF HEMATOLOGY, 1992, 64 (06) :255-259
[14]   INFLUENCE OF CONDITIONING ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GLUCKMAN, E .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (05) :1325-1327
[15]   BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - INCREASED RISK FOR RELAPSE ASSOCIATED WITH T-CELL DEPLETION [J].
GOLDMAN, JM ;
GALE, RP ;
HOROWITZ, MM ;
BIGGS, JC ;
CHAMPLIN, RE ;
GLUCKMAN, E ;
HOFFMANN, RG ;
JACOBSEN, SJ ;
MARMONT, AM ;
MCGLAVE, PB ;
MESSNER, HA ;
RIMM, AA ;
ROZMAN, C ;
SPECK, B ;
TURA, S ;
WEINER, RS ;
BORTIN, MM .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (06) :806-814
[16]  
GREENBERG PD, 1991, ADV IMMUNOL, V49, P281
[17]   INTERFERON-ALPHA AND DONOR BUFFY COAT TRANSFUSIONS FOR TREATMENT OF RELAPSED CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
HERTENSTEIN, B ;
WIESNETH, M ;
NOVOTNY, J ;
BUNJES, D ;
STEFANIC, M ;
HEINZE, B ;
HUBNER, G ;
HEIMPEL, H ;
ARNOLD, R .
TRANSPLANTATION, 1993, 56 (05) :1114-1118
[18]   THE EFFECTS OF CHRONIC INFECTION WITH A SUPERANTIGEN-PRODUCING VIRUS [J].
IGNATOWICZ, L ;
KAPPLER, J ;
MARRACK, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :917-923
[19]   CHARACTERIZATION OF HUMAN COLON-CARCINOMA VARIANT CELLS SELECTED FOR SIALYL LE(X) CARBOHYDRATE ANTIGEN - LIVER COLONIZATION AND ADHESION TO VASCULAR ENDOTHELIAL-CELLS [J].
IZUMI, Y ;
TANIUCHI, Y ;
TSUJI, T ;
SMITH, CW ;
NAKAMORI, S ;
FIDLER, IJ ;
IRIMURA, T .
EXPERIMENTAL CELL RESEARCH, 1995, 216 (01) :215-221
[20]  
JOHNSON BD, 1993, BONE MARROW TRANSPL, V11, P329